Recruiting
The Relation Between Diabetic Neuropathy and Muscle Mass in Type 2 Diabetes Mellitus Patients
The goal of this observational study is to evaluate the relation between diabetic neuropathy in type 2 diabetes mellitus patients and muscle mass
ClinicalTrials.gov IDNCT06958302
PhaseNot Applicable
Enrollment60
SponsorAin Shams University
Age45 Years
SexALL
Conditions studied
Diabetic Neuropathy, Sarcopenia
About this study
The goal of this observational study is to evaluate the relation between diabetic neuropathy in type 2 diabetes mellitus patients and muscle mass
Primary outcomes
- Relation between diabetic neuropathy and muscle mass (Day 1 Neurological examination and clinical physical performance tests for sarcopenia, 2 weeks later: nerve conduction studies for both lower limbs, the 3rd week: ultrasound assessment for thigh muscle thickness)
Eligibility information
Inclusion Criteria:
* The study group consisted of patients diagnosed with Type 2 diabetes mellitus aged ≥45 years old
Exclusion Criteria:
* Type 1 DM, gestational diabetes mellitus
* Severe cardiopulmonary disease, significant/previous neurological disorder (e.g., ischemic stroke, Parkinson disease) causing difficulty during daily activities (e.g., walking), visual deficit, and psychiatric problem
* Other neuropathy-associated factors such as: alcohol, nutrition, poisoning and drug addiction
* Patients with renal diseases, malignancy and autoimmune diseases
* Patients on long term use of Steroids
Study locations
- Ain Shams university, Cairo, Abbassia 00202 Egypt
- Ain Shams university, Cairo, Abbassia 00202 Egypt
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.